Longitudinal evaluation of bone safety in children and adolescents with HIV-1 starting tenofovir alafenamide-containing antiretroviral therapy
{{output}}
Background: Adult participants taking tenofovir alafenamide (TAF) in clinical trials had a better bone safety profile than those taking tenofovir disoproxil fumarate. Herein, we report medium- to long-term effects of TAF-containi... ...
